Cargando…

Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial

OBJECTIVE: The aim of this study was to determine whether a AOI strategy on non-ventilated lung could reduce the regional and systemic proinflammatory cytokine and oxidative stress response associated with esophagectomy, and to evaluate whether AOI can be used as a novel lung protective ventilation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yongtao, Wang, Zhi, Jiang, Feng, Gao, Jie, Li, Yujia, Liu, Siyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290548/
https://www.ncbi.nlm.nih.gov/pubmed/30537951
http://dx.doi.org/10.1186/s12871-018-0652-z
_version_ 1783380109380550656
author Gao, Yongtao
Wang, Zhi
Jiang, Feng
Gao, Jie
Li, Yujia
Liu, Siyuan
author_facet Gao, Yongtao
Wang, Zhi
Jiang, Feng
Gao, Jie
Li, Yujia
Liu, Siyuan
author_sort Gao, Yongtao
collection PubMed
description OBJECTIVE: The aim of this study was to determine whether a AOI strategy on non-ventilated lung could reduce the regional and systemic proinflammatory cytokine and oxidative stress response associated with esophagectomy, and to evaluate whether AOI can be used as a novel lung protective ventilation strategy. Its impact on oxygenation after OLV, surfactant protein A, B, C (SP-A, B, C), postoperative hospital stay and postoperative pulmonary complications (PPCs) was also evaluated. METHODS: Fifty-four adults (ASA II-III) undergoing esophagectomy with OLV were enrolled in the study. Patients were randomly assigned into 2 groups: control group (group C) and treated group (group T). Group C was treated with traditional OLV mode,while group T was given AOI of 5 L/min oxygen on the non-ventilated lung immediately at the beginning of OLV. Arterial blood gas was analyzed before and after OLV. A bronchoalveolar lavage(BAL) was performed after OLV on the non-ventilated lung. Proinflammatory cytokine, oxidative stress markers(TNF-α, NF-κB,sICAM-1,IL-6,IL-10,SOD,MDA) and SP-A, B, C were analyzed in serum and BALF as the primary endpoint.The clinical outcome determined by PPCs was assessed as the secondary endpoint. RESULTS: Patients with AOI had better oxygenation in the recovery period, oxygenation index(OI) (394[367–426] and 478[440–497]mmHg, respectively) of group T at T(2) and T(3) were significantly higher than those (332[206–434] and 437[331–512]mmHg, respectively) of group C. OLV resulted in an increase in the measured inflammatory markers in both groups, however, the increase of inflammatory markers upon OLV in the group C was significantly higher than those of group T. OLV resulted in an increase in the measured SP-A, B, C in serum of both groups. However, the levels of SP-A, B, C of group T were lower than those of group C in serum after OLV, and the results in BALF were the opposite. The BALF levels of SOD(23.88[14.70–33.93]U/ml) of group T were higher than those(15.99[10.33–24.16] U/ml) of group C, while the levels of MDA in both serum and BALF of group T(8.60[4.14–9.85] and 1.88[1.33–3.08]nmol/ml, respectively) were all lower than those of group C (11.10[6.57–13.75] and 1.280[1.01–1.83]nmol/ml) after OLV. There was no statistical difference between the two groups in terms of postoperative hospital stay and the incidence of PPCs. CONCLUSION: AOI on non-ventilated lung during OLV can improve the oxygenation function after OLV, relieve the inflammatory and oxidative stress response in the systemic and non-ventilated lung after OLV associated with esophagectomy. TRIAL REGISTRATION: ChiCTR-IOR-17011037. Registered on 31 March 2017.
format Online
Article
Text
id pubmed-6290548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62905482018-12-17 Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial Gao, Yongtao Wang, Zhi Jiang, Feng Gao, Jie Li, Yujia Liu, Siyuan BMC Anesthesiol Research Article OBJECTIVE: The aim of this study was to determine whether a AOI strategy on non-ventilated lung could reduce the regional and systemic proinflammatory cytokine and oxidative stress response associated with esophagectomy, and to evaluate whether AOI can be used as a novel lung protective ventilation strategy. Its impact on oxygenation after OLV, surfactant protein A, B, C (SP-A, B, C), postoperative hospital stay and postoperative pulmonary complications (PPCs) was also evaluated. METHODS: Fifty-four adults (ASA II-III) undergoing esophagectomy with OLV were enrolled in the study. Patients were randomly assigned into 2 groups: control group (group C) and treated group (group T). Group C was treated with traditional OLV mode,while group T was given AOI of 5 L/min oxygen on the non-ventilated lung immediately at the beginning of OLV. Arterial blood gas was analyzed before and after OLV. A bronchoalveolar lavage(BAL) was performed after OLV on the non-ventilated lung. Proinflammatory cytokine, oxidative stress markers(TNF-α, NF-κB,sICAM-1,IL-6,IL-10,SOD,MDA) and SP-A, B, C were analyzed in serum and BALF as the primary endpoint.The clinical outcome determined by PPCs was assessed as the secondary endpoint. RESULTS: Patients with AOI had better oxygenation in the recovery period, oxygenation index(OI) (394[367–426] and 478[440–497]mmHg, respectively) of group T at T(2) and T(3) were significantly higher than those (332[206–434] and 437[331–512]mmHg, respectively) of group C. OLV resulted in an increase in the measured inflammatory markers in both groups, however, the increase of inflammatory markers upon OLV in the group C was significantly higher than those of group T. OLV resulted in an increase in the measured SP-A, B, C in serum of both groups. However, the levels of SP-A, B, C of group T were lower than those of group C in serum after OLV, and the results in BALF were the opposite. The BALF levels of SOD(23.88[14.70–33.93]U/ml) of group T were higher than those(15.99[10.33–24.16] U/ml) of group C, while the levels of MDA in both serum and BALF of group T(8.60[4.14–9.85] and 1.88[1.33–3.08]nmol/ml, respectively) were all lower than those of group C (11.10[6.57–13.75] and 1.280[1.01–1.83]nmol/ml) after OLV. There was no statistical difference between the two groups in terms of postoperative hospital stay and the incidence of PPCs. CONCLUSION: AOI on non-ventilated lung during OLV can improve the oxygenation function after OLV, relieve the inflammatory and oxidative stress response in the systemic and non-ventilated lung after OLV associated with esophagectomy. TRIAL REGISTRATION: ChiCTR-IOR-17011037. Registered on 31 March 2017. BioMed Central 2018-12-11 /pmc/articles/PMC6290548/ /pubmed/30537951 http://dx.doi.org/10.1186/s12871-018-0652-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gao, Yongtao
Wang, Zhi
Jiang, Feng
Gao, Jie
Li, Yujia
Liu, Siyuan
Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title_full Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title_fullStr Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title_full_unstemmed Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title_short Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
title_sort can apneic oxygen insufflation become a novel lung protective ventilation strategy? a randomized, controlled, blinded, single center clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290548/
https://www.ncbi.nlm.nih.gov/pubmed/30537951
http://dx.doi.org/10.1186/s12871-018-0652-z
work_keys_str_mv AT gaoyongtao canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial
AT wangzhi canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial
AT jiangfeng canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial
AT gaojie canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial
AT liyujia canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial
AT liusiyuan canapneicoxygeninsufflationbecomeanovellungprotectiveventilationstrategyarandomizedcontrolledblindedsinglecenterclinicaltrial